Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 1 |
2006 | 1 |
2008 | 1 |
2011 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouse.
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17141-6. doi: 10.1073/pnas.1104409108. Epub 2011 Oct 3.
Proc Natl Acad Sci U S A. 2011.
PMID: 21969577
Free PMC article.
Clinical Trial.
Neuroprotection for Huntington's disease: ready, set, slow.
Hersch SM, Rosas HD.
Hersch SM, et al.
Neurotherapeutics. 2008 Apr;5(2):226-36. doi: 10.1016/j.nurt.2008.01.003.
Neurotherapeutics. 2008.
PMID: 18394565
Free PMC article.
Review.
Item in Clipboard
Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D.
Cui L, et al.
Cell. 2006 Oct 6;127(1):59-69. doi: 10.1016/j.cell.2006.09.015.
Cell. 2006.
PMID: 17018277
Free article.
Item in Clipboard
In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets.
Zhai W, Jeong H, Cui L, Krainc D, Tjian R.
Zhai W, et al.
Cell. 2005 Dec 29;123(7):1241-53. doi: 10.1016/j.cell.2005.10.030.
Cell. 2005.
PMID: 16377565
Free article.
Item in Clipboard
Cite
Cite